Petplan has announced the winners of its annual Veterinary Awards.
The awards recognise and celebrate staff and practices throughout the country that have delivered an exceptional level of care to the nation's pets and their owners.
Isabella von Mesterhazy, Petplan's Head of Marketing, said: "As the leader in the pet insurance market for over 35 years, we have a rich history of working with veterinary practices across the UK. The Veterinary Awards is a great way to celebrate the fantastic work that goes on helping keep pets healthy and their owners happy."
She added: "This year saw over 11,000 nominations which goes to show the appetite from both staff and clients for celebrating exceptional work. We had an outstanding selection of finalists and I'd like to congratulate all the winners who thoroughly deserve their awards."
The winners for each category are:
VET OF THE YEAR - Laura Pugh, Ashfield House Veterinary Hospital - Long Eaton, NottinghamWhat really stood out was Laura's willingness to go above and beyond the call of duty. As well as Laura's stressful day job she is very involved with the local community. Laura writes an animal column in her local neighbourhood magazine, runs evening talks on a variety of subjects and visits local schools.
VET NURSE OF THE YEAR - Catherine Raw, Broadleys Veterinary Hospital - Stirling, ScotlandCatherine's passion for her role within the practice and her dedication to providing the best service for her clients put her above the other finalists. Catherine is not only committed to her professional role of delivering the highest standard of clinical care for her patients and the best service for her clients, but she also devotes a lot of her own time to animal welfare. Catherine is a fantastic role model for her nurses.
VET SUPPORT STAFF OF THE YEAR - Vivienne Jeffs, Arvonia Animal Hospital - Cheltenham, GloucestershireVivienne's reliability, empathy and selflessness really stood out for the judges. Whether it is knowing the name of a pet owner during telephone conversations, or entertaining toddlers in the waiting area, Vivienne is the type of receptionist vet surgeries dream of. The practice would not be the same without her according to those that nominated her.
VET PRACTICE OF THE YEAR - Bridge Veterinary Surgery - Highbridge, SomersetThe practice's hard work and dedication to their clients really impressed the judges. The practice is open 24 hours a day and the dedication the veterinary, with a small practice of only four staff members, it is a particularly well deserved award.
VET PRACTICE MANAGER OF THE YEAR - Cery Lawson-Tankred, Golden Valley Veterinary Hospital - Nailsea, SomersetCery has worked at Golden Valley for over five years, during which time the practice has seen a large degree of upgrade and reinvigoration. Investments made in new equipment and facilities have meant improved care for an expanding array of animals that come through the surgery doors. It was clear to the judges that Cery is the glue that holds the Golden Valley Veterinary Hospital together.
The Feline Advisory Bureau (FAB) has changed its name to International Cat Care in order to better reflect the work the charity does to help improve the lives of cats both in the UK and internationally.
Along with the name change, the charity has developed a completely new visual identity, which has been applied to its new website (www.icatcare.org).
Claire Bessant, CEO of International Cat Care, said: "We continue to evolve as a charity and we are increasingly working internationally to help vets and local communities provide better care for cats. While our mission and core values will remain the same, we needed a strong brand identity to better reflect this work and to help us engage more directly with consumers and vets."
Underneath the International Cat Care umbrella, there are three core areas which are designed to help streamline the charity's work and make it easy for vets, professionals and consumers to engage in the right way. The three areas are:
The charity's new website will continue to host information and advice on virtually every aspect of cat care, but also showcases the charity's work internationally. Most recently, the team has been in Sudan teaching vets about the safe handling and neutering of cats, with a special emphasis on street cats.
Claire Bessant continued: "We really wanted to achieve a clear and succinct explanation of who we are and what we do, and we think the new name and visual identity perfectly sums this up. It's been such a rewarding process because the rebrand has been so positively received by our dedicated staff, members and supporters."
International Cat Care will be officially unveiled on the first day of this year's BSAVA Congress, where vets and the media will be invited to the stand to see the new identity for the first time, and for a glass of celebratory champagne.
To meet the team and find out more about the rebrand, visit stand 704 at the BSAVA Congress.
The BSAVA and Vets Now have signed a partnership agreement to develop a new postgraduate certificate in emergency and critical care (ECC).
The programme, which will follow the same broad structure as BSAVA's existing postgraduate certificate, will take its first group of students in May 2014.
Prof Michael Day, pictured above with Amanda Boag at BSAVA, said: "This is an exciting development to develop a qualification which will be relevant and accessible to vets in practice."
Amanda Boag added: "The combined expertise of both organisations will result in an engaging and high quality qualification in this field."
Pets at Home has announced the acquisition of the joint venture practice business, Vets4Pets, adding 93 stand-alone veterinary practices to the 116 in-store practices it already operates under the Companion Care brand.
Providing veterinary and grooming services to consumers is seen as the way for the retailer to overcome competition from the Internet.
Nick Wood, CEO of Pets at Home said: "The expansion of our veterinary business is a key element of our growth strategy for Pets at Home, providing additional services to our customers within our stores or close to our customers' homes. The acquisition of Vets4Pets is an important step in the delivery of this strategy. Vets4Pets is highly complementary to Companion Care, sharing fundamental beliefs and values, and is an excellent strategic fit for Pets at Home. I am delighted that Peter Watson has agreed to stay with the business. His knowledge and experience will be invaluable as we continue to build our veterinary business with both stand-alone and in-store practices. He will work closely with Jane Balmain, the Managing Director of our Companion Care business as we integrate the two businesses."
Peter Watson, Founder and CEO of Vets4Pets said: "Pets at Home holds a unique place in the retail landscape, built on a strong identity and a real passion for people and pets. It is clear to me that Nick and his team have a similar vision for their veterinary business. I'm delighted to be working with Nick to continue to expand the veterinary business by offering attractive joint venture opportunities for vets in stand alone locations to complement the offering in Pets at Home stores."
Companion Care MD, Jane Balmain added: "Companion Care and Vets4Pets each enjoy a strong reputation among both vets and customers. Both businesses have a common business model, offering joint venture partnerships with vets. I am looking forward to working alongside Peter as we bring the businesses together, continue to expand our joint venture partnerships and accelerate our growth."
Vets4Pets' UK operational centre will remain in the East Midlands, with its support functions being split between Companion Care's operation in Oxfordshire and Vets4Pets' Guernsey office.
Novartis Animal Health has announced that it has assumed marketing responsibilities for the joint health supplement Cosequin in the United Kingdom and Ireland.
Cosequin, which contains glucosamine and chondroitin sulfate, is available in a range of presentations for dogs, cats, and horses.
The product, which was previously marketed by MSD, is the leading joint health supplement among veterinary surgeons in the US and Europe.
Novartis says Cosequin is an important addition to its Orthopaedic Health Category, which in 2009 introduced Onsior (robenacoxib), the first tissue-selective pain relief for cats and dogs.
Gaynor Hillier, General Manager UK & Ireland Novartis Animal Health said: "Our strategic intent is to expand our presence in orthopaedic health to address prevention, diagnosis, and treatment in a more comprehensive manner. Cosequin represents an important step toward achieving this objective".
Cosequin is available from Novartis Animal Health in the United Kingdom and Ireland, from licensed veterinary wholesalers. For more information on Cosequin, contact your Novartis Animal Health Territory Manager.
The Royal College is inviting veterinary surgeons to the first-ever Virtual Question Time, which is being held online with The Webinar Vet, from 8-9.30pm on Wednesday 24 April.
Lizzie Lockett, Head of the RCVS Communications Department said: "This is an ideal opportunity to put your burning questions to members of the RCVS Officer team and to VN Council. Our regular Question Time meetings are popular, so we are following their format by asking delegates to set the agenda via their choice of questions. This time there is the extra advantage that busy vets and nurses can take part from the comfort of their own homes. If the Virtual Question Time proves successful, we may hold these events regularly."
The meeting will be run as a free, live-audio webinar. RCVS President Jacqui Molyneux will open proceedings, and introduce the panel, before answering questions from the participants.
Questions may be put to the College in advance and can also be submitted as discussion unfolds on the night. These can be on any issues affecting the veterinary and veterinary nursing professions - there is no set agenda - and might range from the First Rate Regulator initiative, new vet schools, veterinary nurse training and clinical governance, to proposed changes to the Practice Standards Scheme and recent amendments to the Veterinary Surgeons Act.
The session will also be recorded so those unable to attend on the night can still listen afterwards.
The meeting can be counted towards continuing professional development for veterinary surgeons and veterinary nurses. Registrations and questions can be submitted online at http://thewebinarvet.com/rcvs/#.
Virbac has announced the launch of My Virbac, a new website offering a range of business, marketing and technical services for veterinary professionals.
The main elements of My Virbac are:
Virbac Product Manager, Ms Victoria Hudson said: "Virbac was one of the pioneers of the concept of practice support and the services we already offer are highly valued by our customers. In developing My Virbac, we're taking things to a new level. We've worked with business and veterinary experts to develop a practical and helpful range of services which will make a real difference to practices that use them. We plan to add additional services and tools on a regular basis.
"As the veterinary sector becomes increasingly competitive, providing an outstanding clinical service is no longer enough. Practices must also be well-run businesses, with a strong focus on marketing and client retention. Taking advantage of the services and tools available on My Virbac will help practices to ensure they are well placed to succeed even in difficult times."
To access Virbac's services platform, practices and individuals can register at www.my-virbac.co.uk.
The Born Free Foundation, British Veterinary Association, Captive Animals' Protection Society and the RSPCA have welcomed the Government's draft legislation to ban the use of wild animals in circuses in England, to be implemented in 2015.
The groups, which have worked closely together for a number of years on the campaign to seek an end to the use of wild animals in big tops in the UK said that they were "delighted" to see the ban brought forward in concrete terms.
A spokesperson, talking on behalf of all four leading organisations said: "We are pleased to see that the Government appear to have come good on their promise to ban the outdated practice of using wild animals in circuses.
"We have long argued that the complex needs of wild animals cannot be met in a travelling circus environment and were disappointed when the Government introduced a licensing regime earlier this year which appeared to legitimise a practice which we, and our hundreds of thousands of supporters, want to see abolished altogether.
"We are looking forward to seeing the ban fully implemented at the earliest opportunity".
BVA President Peter Jones said: "Whilst there are only 20 wild animals kept by two licensed circuses in the UK, their welfare is emblematic of the way we treat all animals."
The groups said that they would work to support Government in the formal enactment of the Bill and the Born Free Foundation and the RSPCA reiterated their pledge to offer to find safe homes for life for all wild animals currently being used in English circuses.
Animalcare Ltd has launched Marbocare (marbofloxacin) 100mg/ml solution for injection, a third-generation fluoroquinolone for the treatment of E.coli mastitis and bovine respiratory disease (BRD) in cattle, and Metritis Mastitis Agalactia in pigs.
The company highlights the product's unique flexible dosage regimen of once daily injections for 3 days against E.coli mastitis and BRD, plus a single intramuscular (IM) high dose (8mg/100kg) for BRD.
Animalcare says this regimen, coupled with the flexibility of administration afforded by all three injection routes (intravenous IV, subcutaneous SC and IM), a low volume dose and good syringeability, all combine to offer ease of use; resulting in a reduction in handling and less stress for the cattle.
Developed for veterinary use only, Marbocare has broad spectrum activity against Gram+ve and Gram-ve pathogens. Animalcare says the product is especially effective against E.coli mastitis and the key bacterial pathogens associated with BRD, as well as M.bovis.
Marbocare has milk withdrawal times of 36 hours after the last treatment following the 3 day course and 72 hours after a single shot for BRD. Meat withdrawal is 6 days after multiple injections and 3 days after the single shot.
Marbofloxacin has proven efficacy in a comparative international, multi-centre, controlled, randomised field trial1 in 62 dairy cows with E.coli mastitis. Marbofloxacin cure rates were significantly higher than the control product. In respiratory disease it showed a more rapid clinical response in comparison to tilmicosin2, ceftiofur3 and oxytetracycline4. Marbofloxacin was shown to be well tolerated, leading to a fast return to appetite, liveweight gain and associated welfare benefits.
Marbocare is also licensed in the treatment of Metritis Mastitis Agalactia syndrome in pigs, given by IM injection, with a 4 day meat withdrawal.
Tony Liepman, Product Manager from Animalcare said: "Marbocare is competitively priced whether used on its own or alongside a single-dose anti-inflammatory such as Emdocam (meloxicam)."
Marbocare is a POM-V licensed product presented in 50 and 100ml multi-dose vials.
References
Virbac has launched Inflacam, a meloxicam-based NSAID for the alleviation of pain in both acute and chronic musculo-skeletal disorders in dogs and horses.
Inflacam is presented both as an oral suspension and as a chewable tablet for dogs. The suspension is available in 200ml, 100ml, 42ml and 15ml sizes with a measuring syringe provided. The tablets come in two sizes - 1 mg and 2.5 mg - and are available in packs of 100. It is available for horses as an oral suspension.
Virbac Product Manager Chris Geddes MRCVS, said: "Virbac is well known for launching innovative products in areas such as dermatology and reproduction but we also aim to support practices by offering tried and trusted practice 'standards' for everyday use. Inflacam fits this brief well - meloxicam is the most commonly-used NSAID in dogs and we are delighted to add it to our range."
For more information contact your territory manager or call Virbac on 01359 243 243.
Ceva Animal Health has launched Marboxidin chewable tablets for dogs and cats for the treatment of micro-organisms susceptible to marbofloxacin, including skin and soft tissue infections (in cats and dogs), respiratory tract infections (in dogs and cats) and urinary tract infections (in dogs).
Containing marbofloxacin as its active ingredient, Marboxidin has a taste-masking lipid coating to ensure that its bitterness is not detected. In palatability trials over 90% of dogs and 80% of cats voluntarily consumed Marboxidin chewable tablets from the hand or in food1. Ceva says that Marboxidin is also very cost-effective, with an ongoing discount using the new CevaSave rebate scheme.
Marboxidin chewable tablets are available in three tablet sizes (5mg, 20mg and 80mg).
For further details, contact your Ceva Territory Manager or telephone the customer support team on (01494) 781510.
The WSAVA's Global Nutrition Committee (GNC) has launched a Nutrition Toolkit for veterinary professionals.
The non-branded toolkit contains the following materials:
The toolkit is available for download at http://wsava.org/nutrition-toolkit.
Based on its importance to overall health, the WSAVA is campaigning to have a nutritional assessment confirmed as the fifth vital assessment in a standard physical examination and for the veterinary healthcare team to provide nutritional recommendations for each animal as an integral component of patient care.
The launch of the Nutrition Toolkit follows on from the Global Nutrition Committee's first initiative, the creation of a set of Nutrition Guidelines in 2011. These were aimed at helping veterinary professionals and pet owners ensure that pets are fed according to an optimal and individually tailored nutrition plan. According to WSAVA, they have been successful, securing endorsements from 19 veterinary organizations in 16 countries. They have been translated into ten languages and are available for download at http://www.wsava.org/guidelines/global-nutrition-guidelines.
GNC Co-Chair Dr Marge Chandler said: "Research shows that more than 90% of pet owners would like nutritional advice but fewer than 15% feel they receive it. In some parts of the world, pet malnutrition remains a major challenge, while in many other countries, pet obesity is an increasing problem. In addition, there is confusion about optimal nutrition because there is now so much conflicting and inaccurate information available online.
Our Nutrition Toolkit is designed to help the veterinary healthcare team address nutrition at every patient visit and to advance the central role of the veterinary healthcare team as the expert source of nutrition information."
Owners of hyperthyroid cats say they would rather veterinary surgeons prescribed the appropriate dosage for their pets than have an easy way to administer the medicine, according to new research carried out by feline expert Dr Sarah Caney BVSc PhD DSAM (Feline) MRCVS.
111 cat owners were questioned for the research, which was supported by Dechra Veterinary Products and has been accepted for publication in the Journal of Feline Medicine and Surgery.
Dechra says the results of the study challenge long-held perceptions, and should encourage a reappraisal of the approach to oral anti-thyroid medication:
89% of cat owners agreed with the statement that it 'was more important to me that the vet prescribes the most appropriate dose for my cat than that they provide me with an easy method of administering the medicine.'
Dr Caney said: "The survey has shown that cat owners are not a barrier to prescribing twice daily medication. Their overwhelming drive is to provide the best level of care that they can.
"From an owner perspective, the ideal anti-thyroid medication offers low doses and a variety of dosing strategies to ensure that each individual cat receives the dose they need and no more."
The findings revealed that 'once daily treatment' was not ranked as the most important statement on dosing by any of the owners and that only 21% of owners who had experienced oral dosing of their cat described the process as either 'tricky' or 'very difficult'.
Craig Sankey, Brand Manager for Felimazole at Dechra Veterinary Products, said: "We are very pleased to have supported such an important piece of independent research relating to feline hyperthyroidism which challenges some of the assumptions made about owner needs.
"Ease of administering the medicine is not the overwhelming issue for owners of cats with hyperthyroidism - administering the correct dose is. In fact, 79 % of cat owners questioned were happy to give pills twice a day if necessary."
To see the latest research in full, please visit www.dechra.co.uk/hyperthyroidism
Boehringer Ingelheim Vetmedica has launched Pexion (imepitoin) a novel treatment for canine idiopathic epilepsy.
Canine epilepsy can affect up to 5% of dogs6. In most dogs diagnosed with idiopathic epilepsy no underlying cause for the seizures can be found. While the condition can affect any dog, it is more common in young (one to five year old), purebred dogs such as Labradors, Golden Retrievers, German Shepherds, Boxers, Vizlas, Beagles, English Springer Spaniels, Irish Setters, Poodles and Dachshunds.
Boehringer says Pexion has a highly targeted mode of action1-3 to suppress a dog's seizures. It starts to work within a few hours and reaches steady state within three days4,5. Boehringer claims this will make it easier to stabilise epileptic patients. It also says there is no evidence of hepatotoxicity or liver-associated enzyme elevation, so repeated blood tests for liver enzymes or therapeutic levels are no longer required.4,5
Pexion is available in 100 mg and 400 mg tablets. The tablets are white, scored and divisible in half. Both tablet strengths are available in 100 tablet packs from veterinary wholesalers.
Jemima Mead, brand manager at Boehringer said: "Pexion is a ground-breaking new product which gives vets a new first-line treatment option for dogs with idiopathic epilepsy, improving the lives of newly diagnosed epileptic dogs and their owners by reducing the number of seizures and their impact on the patient's life".
To support the launch of the new product, Boehringer hosted an epilepsy webinar presented by neurologist Dr Holger Volk DVM PhD DipECVN FHEA MRCVS, recognised RCVS and European Specialist in Veterinary Neurology. The webinar is now available on demand at www.bi-academy.co.uk.
For further information on Pexion visit www.pexion.co.uk, contact your local Boehringer Ingelheim territory manager or telephone +44 (0)1344 746959.
Invicta Animal Health has launched EthyCalm Spray, a cryoanalgesic for minor procedures.
The active ingredient, ethyl chloride, acts as a local analgesic (pain relief) when sprayed or wiped onto the skin.
According to the company, the product is effective in a few seconds and works for a few minutes until the skin warms up again. This makes it suitable for such things as venepuncture, tick removal or placing of PVC's, where it should help reduce stress for the patient and the practitioner.
Ethycalm is presented in a 50ml vial which provides up to 100 applications.
Rob Watkins, Managing Director of Invicta, said: "We are delighted to launch EthyCalm. During theatre training sessions for our product, ChloraPrep, we realised that the busy nurse doesn't have time to use traditional analgesia methods such as creams. They needed something instant yet cost-effective. Seeing the widespread use of ethyl chloride in places like Great Ormond Street Hospital, it was obvious that this product needed to be made available to veterinary practices".
For further information see www.invictavet.com or phone 01403 791313
Novartis Animal Health has announced the launch of a new campaign called Prepare, Predict, Prevent and designed to raise awareness of blowfly strike management in sheep.
The campaign will include new industry research, an expert-led report, and information tailored to farmers, veterinary surgeons and SQPs. The campaign is aimed at improving awareness of blowfly strike management, with a particular focus on prevention.
In the UK, blowfly strike (myiasis) occurs on over 80 per cent of sheep farms2. If untreated, strike can severely affect the welfare of infested sheep, and may result in death. For farmers, poor management of blowfly strike brings economic costs in terms of the loss of animal, production losses and in terms of treatment and control of the disease, which is easily spread.
Furthermore, previous research from the University of Bristol4, which simulated the pattern of parasite growth in different climate-dependent environments, showed that an increase in average temperature of 3 degrees Celsius would be enough to quadruple the incidence of strike in ewes and double the rate in lambs. This is a growing concern, with climate change models for the UK suggesting that over the next 50 years summer temperatures are set to increase by 1.5 degrees Celsius and winter temperatures by 2.5 degrees Celsius5.
Research conducted at the 2013 Animal Health Distributors Association (AHDA) Annual Conference indicated that, in the past five years, many believe the blowfly strike season is lasting longer and beginning earlier in the year, with the majority of early reported cases occurring unexpectedly in March. The findings have prompted a wider survey from Novartis Animal Health, which is urging SQPs, farmers and key opinion leaders nationwide to contribute answers at: www.farmanimalhealth.co.uk/fleecebind-questionnaire.
Katherine Openshaw, Ectoparasiticides Category Manager at Novartis Animal Health, said: "This has always been a serious issue for the sheep industry and elevated temperature is likely to bring about increased levels of blowfly strike and a longer season.
"We recognise the need to evolve attitudes towards parasite control and to provide farmers and prescribers with the knowledge and tools needed to facilitate a better management of blowfly strike. The 'Prepare, Predict, Prevent' campaign is all about simple, yet effective, measures to prevent the occurrence of blowfly strike, which can be enough to ensure farmers are protected from the potentially devastating impacts of flock infestation, offering season peace of mind.
"We have developed a range of materials to aid prescribers in promoting preventative solutions to farmers; these include farmer leaflets, posters and counter displays. We will also be offering training support so prescribers are best equipped to help farmers make informed decisions about preventative blowfly solutions."
To what extent changing diets and adding novel feed additives can cut emissions from beef cattle is being investigated in a new three-year research project.
EBLEX, the organisation for beef and sheep producers in England, has teamed up with Scotland's Rural College, SRUC, in Edinburgh, to look at how changes to feeding regimes can improve efficiency and drive business profitability, while reducing greenhouse gas (GHG) emissions produced as a by-product of rumination.
Steers will be finished on either concentrate based or forage based diets, each with two different feed additives, such as vegetable oils. The role of the rumen microbial population in the responses will be measured to look at how rumen function changes according to diet, additive and breed. Results will be related to the greenhouse gas emissions and feed efficiency, as well as long-term effects of feed additives.
Dr Mary Vickers, senior livestock scientist with EBLEX said: "The animals will be moved into specialist chambers for short periods of time where their emissions can be captured.
"In addition, when they are accessing rations from group pens, special plastic hoods over the feeding stations can measure the specific emissions at those times. Measuring emissions, rumen function, feed intake and growth rates can help us build a picture of any effect the additives have.
"The ultimate aim is to ensure the cattle are having their full nutritional needs met in an efficient, cost effective way while minimising the emissions produced."
In addition, carcase quality, meat quality and shelf life will also be recorded to ensure quality of the final product is maintained. The outcomes of this project will provide producers with independent advice about the efficacy of two feed additives fed in a range of commercial conditions.
Bayer Animal Health has announced the launch of a new campaign which plays on our anthropomorphic nature to drive owners into practice for worming.
As part of the campaign, the company has enrolled the behaviour specialist and author Sarah Whitehead to oversee a video analysis of the behavioural interaction between a small number of dogs and their owners. The results will be used to make an educational film for pet owners which helps them better understand their pet's emotions and behaviour.
Tracey Dawson, Group Product Manager at Bayer Animal Health said: "We want owners to really understand the importance of health on their dog's happiness and behaviour, whilst reminding them to worm their pet at least four times a year. Our ground breaking research will make owners feel like real-life Dr Doolittle, as they will better understand their pet's emotions and actions, highlighting the importance of keeping their dogs healthy, happy and worm-free."
In order to prompt owners to worm their dog more frequently, Bayer has also launched a free SMS/email worming reminder service available at www.drontal.com. In addition, there'll be a new CPD section for SQPs on the website in the summer..
Bayer is also developing 'Worm Reminder' toolkits for veterinary practices, including a press release template, infographics, and video report of the research findings to further promote the importance of worming frequently. For more information, talk to your Bayer representative.
Petplan has announced the finalists for the inaugural Petplan and Association of Dogs and Cats Homes (ADCH) Animal Charity Awards.
The awards have been set up by Petplan to celebrate the outstanding work of animal charities and not-for-profit organisations across the UK.
The finalists for each of the categories are:
Animal Charity Team of the Year
Animal Charity Volunteer of the Year
Animal Charity Employee of the Year
Simon Masding, Petplan's Head of Sales and Partnerships said: "Animal wellbeing is central to all we do at Petplan. We work with over 1,500 animal charities and give over £2million to assist them every year. The Petplan and ADCH Animal Charity Awards is another way for us to support and recognise the teams and individuals at charities dedicated to improving the lives of animals. We're delighted that these new awards have got off to a fantastic start with over 3,400 nominations from adopters, supporters, charity staff and volunteers."
Winners will be announced on the 2nd May in an awards ceremony in Stratford-upon-Avon. For further information go to www.petplan.co.uk/charityawards
The RCVS has released the results of a survey which has found that increasing numbers of graduates over the last five years have had little impact on veterinary job prospects.
The survey was carried out for the RCVS by the Institute for Employment Studies, which asked the last five years' UK graduates who have registered with the College how long it took them to find work, how long they stayed in their first jobs, and why they moved on.
The online survey, which achieved a 43% response rate (1,354 responders), found that an average of 94% of graduates seeking a role in clinical practice obtained work within six months of starting to look.
The actual figure ranged from a high of 96% in 2008 to a low of 92% in 2010, and did not change significantly over the five years under consideration, despite UK graduate numbers increasing by around a quarter during the same period (from 650 in 2007, to 819 in 2012). Meanwhile, the College has registered an average of 618 overseas graduates annually during this time.
The survey did show that it was taking graduates slightly longer to secure their posts, with a shift from 85% securing work under three months in 2008, to 71% in 2012.
The results seem to suggest some small differences in the time taken for men and women to find their first jobs, with men finding jobs slightly quicker, although the vast majority of both genders found veterinary work.
Jacqui Molyneux, RCVS President said: "After the announcement from the University of Surrey that it will be opening a new vet school in the near future, there was a great deal of discussion amongst the profession about how easily new graduates could find employment. I undertook to get some real facts and am pleased to find that the picture is not as gloomy as predicted.
However, Jacqui said she was concerned that there has been a slight increase in the proportion of respondents who left their first position after a relatively short period of time. Amongst 2012 graduates, over 40% of those who had left their first position did so within three months of starting work. However it must be stressed that only 18% of those answering the survey who graduated in 2012 had already left their first position. Jacqui said: "Although the turn-over in first jobs seems to be, in part, due to an increase in temporary posts, I am saddened to see that the most commonly-cited reason for graduates leaving their first job was lack of support from their employers or professional colleagues.
"This is an area that we, as a profession, must address. As I have told all the students I have admitted to the College, their first jobs will influence their whole careers, and getting adequate support is probably the single most important factor. Meanwhile, it is heartening to see that nearly all of those moving on have obtained further employment."
Although the survey was sent to all those UK graduates who had registered with the RCVS within the last five years, the contact details for those who had subsequently de-registered may not have been up to date, which may mean that those who had de-registered because they could not find work were not well represented. However, the College says it thinks it is more likely that these individuals would have switched to the 'non-practising' category.
A summary of the headline survey results will be available at www.rcvs.org.uk/publications. The full findings, which also looked at the time taken to complete the Professional Development Phase and the type and location of work sought, will be available in due course.
The RCVS Charitable Trust, has announced a complete rebranding that includes a change of name - RCVS Knowledge - and the refocus of its mission on supporting the flourishing evidence based veterinary medicine (EBVM) movement across the globe.
For the past 50 years, the charity has been known as a small funder of veterinary research and the home of the only freely-accessible library for the practising veterinary community in the UK.
Nick Royle, Executive Director of RCVS Knowledge said: "RCVS Knowledge is a name that encompasses our three core offerings: historical knowledge represented by our valuable Historical Collection, present knowledge, represented by our library, and future knowledge, represented by the new evidence based veterinary medicine project, which is underpinned by our grants programme."
The RCVS Knowledge re-launch goes further than a mere name change, and comes as the charity refocuses its efforts to become a global intermediary for EBVM, a direction reached following a period of consultation, and on the back of a successful symposium on the subject held at the end of 2012.
Nick, a former CEO of the human evidence based medicine resource, The Cochrane Collaboration, said: "Today, veterinary surgeons and nurses are required to take account of an ever-increasing pool of scientific data, the owners' values and preferences, and their own clinical expertise when making clinical decisions. RCVS Knowledge is ideally placed to generate, collate and distribute this information to support evidence based practices. We aim to develop tools to assist practitioners to quickly make well-informed treatment decisions."
As part of the new direction, the Historical Collection will be made accessible and available online, following a start-up grant from the Wellcome Trust. Clare Boulton, Head of Library and Information Services, said: "The Collection contains priceless and fascinating material, covering topics such as early horse-care and management, veterinary expeditions of discovery through Africa, and research that made the British Cavalry horses of 1914 the finest in the world. But this is just the beginning. If you have relevant experience or some funds that could help us, please get in touch."
Meanwhile, RCVS Knowledge's Library and Information Service will be re-designed to make it much more than shelves of journals, but rather a resource with the capacity to steer first-rate care and innovation, and an information engine capable of driving evidence based veterinary medicine at a global level.
The Grants and Awards program, for which the former RCVS Charitable Trust has been known, will be redesigned to celebrate professional excellence, and to address gaps in veterinary knowledge. Nick said: "We are aware of the responsibilities that veterinary surgeons and nurses face every day and feel we are in a position to support their decision making. We would like to urge every veterinary professional with an interest in EBVM, a curiosity about the history of their profession or a need to access up-to-date research to get in touch, so that we can keep you up to date with developments."
Maggie Fisher MRCVS, the parasitologist and chairman of ESCCAP (European Scientific Counsel Companion Animal Parasites), has highlighted studies which demonstrate an association between the common parasite, Toxocara spp. and human disease, and has called on the profession to help reduce the damaging and widespread effects of this parasite.
Maggie says that many in the profession may not be aware that Toxocara eggs aren't actually infective when they are first passed in an animal's stools, sometimes taking weeks to develop to this stage. Eggs persist long after pet waste has naturally washed away too, so the risk of infection still exists even in environments that appear to be clean and safe. Interestingly, there seems to be only a very loose (and according to some studies, entirely absent) link between owning a pet and an increased risk of human Toxocara infection, suggesting that most infections are acquired from the environment1,2 . Education of pet owners about responsible pet ownership, including appropriate worming and picking up their dog's waste quickly is essential to reduce this environmental infection risk.
The parasite's larval stages cause disease in humans as they migrate through body tissues, with retinal damage a previously well identified consequence. However, Maggie has identified studies which suggest a whole range of common conditions that may also be attributable to Toxocara infection. One study3 included 425 children displaying signs of a persistent cough and 1600 asymptomatic children as controls. Blood tests confirmed that a statistically significant 32% of the symptomatic group were positive for Toxocara antibodies, compared to just 17% of the asymptomatic control group. What's more, when given a week's course of an appropriate anthelmintic, the vast majority of symptomatic children had a greatly reduced and frequently absent requirement for inhaled corticosteroids to control their symptoms when re-examined by the study team a year later.
Numerous other studies from around the world have shown similar strong associations with asthma, allergies and epilepsy. One nationally representative US study even showed an alarming association with Toxocara infection and reduced cognitive function in children2 . Those that were positive for antibodies to the parasite on blood tests (proving prior exposure) scored significantly lower on tests assessing verbal and manual dexterity as well as maths and reading abilities2 .
So, what should veterinary staff and SQPs be telling clients? Maggie says you should be advising pet owners to worm pets regularly (at least four times a year) with an effective anthelmintic from an appropriately young age (2 weeks of age for puppies and 3 weeks of age for kittens, because transfer of the parasite to puppies before birth and to kittens via milk is a feature of the parasite lifecycle). Reducing pets' access to raw food and hunting activities can also help. This is in addition to more general recommendations including cooking food well and making sure children wash their hands before eating.
Maggie said: "Vets, nurses and SQPs are perfectly placed to make sure that pet owners are aware of the risks and take precautions to protect themselves and the wider general public."
For further information about effective control of Toxocara and a wide range of other companion animal parasites, visit www.esccapuk.org.uk. To view all the presentations from the 'Everyday Parasites' CPD day, visit www.esccapuk-cpd.co.uk.
References:
The British Veterinary Association has expressed concern about an increasing trend towards temporary contracts for new graduates following the release of headline figures of a survey by the Institute for Employment Studies on behalf of the RCVS.
The survey showed that the percentage of graduates leaving their first job within the first three months has significantly increased for those who graduated in 2012 and who have already left their first position. Amongst vets who graduated in 2010 and had already left their first job 7.7% had done so within the first three months; for 2011 graduates this figure is 15.9%; and for 2012 graduates it is currently 42.6%, although this percentage is likely to decrease over the next year as more of the 2012 cohort leave their first roles. The two main reasons given for leaving first jobs are poor management and temporary contracts.
Besides this unexpected increase the survey showed little change in other areas for recent graduates, although there has been a slight increase in the amount of time taken for new graduates to find their first job. The survey also revealed that over the 5 year period 16% fewer graduates found jobs in under 3 months.
BVA President Peter Jones said: "Information in this survey and that conducted by the British Equine Veterinary Association recently is valuable evidence of how the changing environment affects those entering our profession and will feed into the on-going discussion at BVA on veterinary workforce issues.
"Perhaps most worrying is the statistic that the percentage of graduates leaving their first job within the first 3 months has significantly increased. The main reasons cited are poor management and temporary contracts. The trend towards temporary contracts is very worrying in terms of job security for those just starting out in our profession.
"Poor management has long concerned the BVA and is what initially led us to establish initiatives such as the Young Vet Network, the recent graduate guide and our contracts of employment campaign. We are currently working on building that support and we are in the process of widening the network of graduate support meetings to help with moral support and networking opportunities. We also supporting the RCVS's Professional Development Phase to support new graduates in their first few years of practice and have produced a number of resources to assist with this process."
While the results show little evidence of a major impact on job prospects from the increase in graduates since the opening of Nottingham Veterinary School, BVA members remain concerned about the impact of a new school opening next year such as the one planned at the University of Surrey.
Peter Jones continued: "It is reassuring to see that overall trends are not changing significantly, however, the ease with which our graduates are getting jobs is changing. We will therefore be considering in some depth the impact that two, three or more new veterinary schools could have in the future. Rumours of yet more new veterinary schools elsewhere are a serious worry for the profession.
Norbrook Laboratories has announced that Pestigon for Cats, the company's fipronil spot on solution against fleas and ticks, has been granted an extension to its licence which means it is now indicated against the Ixodes ricinus tick.
Previously, the cat product was only indicated for Dermacentor reticulatus.
The Pestigon dog spot on offers efficacy against the Dermacentor reticulatus, Rhipicephalus sanguineus and the Ixodes ricinus tick.
Michelle Jones, Norbrook's Small Animal Brand Manager said: "The extension of our licence for Pestigon in Cats is welcome news. The Ixodes ricinus tick is one of the most common ticks found in the UK. Pet owners need to be aware that choosing a treatment that kills ticks as well as fleas is vital, with ticks potentially spreading diseases such as lyme disease. We are therefore delighted that our Pestigon range now gives cat owners even more protection against fleas and ticks."
Michelle added: "Pestigon is only available through veterinary practices which means that pet owners have to visit their practice to purchase this flea and tick treatment. They can therefore receive expert advice at the point of purchase and discuss any concerns they may have."
Pestigon spot on is available from all wholesalers in packs of 3, 6 and 24. Norbrook also makes a household spray, Permaguard, and a range of customer support materials available from Norbrook Territory Managers.
Image: Ixodes ricinus Richard Bartz
The RCVS has announced that the first members of its reconstituted Disciplinary and Preliminary Investigation Committees have been appointed and will join the Committees from July 2013.
Beverley Cottrell and Catherine Goldie (pictured right) have been appointed to the new Disciplinary Committee (DC), and are retiring as elected veterinary surgeons on Council to take up the posts. Veterinary surgeons Jane Downes and Charles Gruchy, and lay members Stuart Drummond, Ian Green, Chitra Karve and Mehmuda Mian, will also join the DC.
The new Preliminary Investigation Committee (PIC) members will include veterinary surgeons Andrew Ash and William Reilly, plus lay members Penny Howe, Sarah Pond and Elana Tessler.
These new appointments result from a legislative reform order (LRO) made to separate the RCVS disciplinary committees from the RCVS Council. The Royal College says this will improve the independence of the disciplinary process and bring it into line with regulatory best practice.
The LRO came into force on 6 April 2013, and amended the Veterinary Surgeons Act 1966 (VSA). The VSA now requires that the RCVS PIC and DC are made up of veterinary surgeons and lay members who are not RCVS Council members, and who are appointed independently. The change to the legislation ensures that the same group of people is not responsible for setting the rules, investigating complaints, and adjudication.
The LRO also brings lay people formally into the PIC and will increase the pool of people available to investigate complaints and sit on disciplinary hearings.
RCVS Registrar and Head of Legal Services, Gordon Hockey said: "The LRO fundamentally improves the way the veterinary profession is regulated, and will help to ensure public confidence in our disciplinary processes. I am delighted by the constructive and collaborative working relationship that we had with Defra and the British Veterinary Association (BVA), which has allowed this major reform to be introduced."
To make these appointments, a long-list of lay and veterinary surgeon candidates was put together by recruitment consultants, and a shortlist was referred to an independent selection committee chaired by Sir Michael Buckley and including Christopher Laurence and Dr Joan Martin. The selection committee's choices were then ratified by RCVS Council at the June 2013 meeting.
As part of a transition phase, both committees will also include some Council members; after a two-year period, members of RCVS Council will become ineligible for membership of either committee.